Michael Hunter, MD
Orthopaedic Surgery · Newport Beach, CANPI 1346622040
Payments from drug & device makers
Across 147 payments — averaging $955.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$123K
- Medical Device Business Services, Inc.$8K
- Zimmer Biomet$7K
- Omnilife Science, Inc$1K
- Peerless Surgical Inc.$820
- Atricure, Inc.$217
- plus $483 from 5 others
What the payments were for
- Consulting fees$77,43855%
- Speaking & faculty fees$36,52826%
- Travel & lodging$10,1437%
- Food & beverage$5,5384%
- Education$10,8208%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 96 | $122,921 |
| Medical Device Business Services, Inc. | 9 | $7,543 |
| Zimmer Biomet | 18 | $7,251 |
| Omnilife Science, Inc | 7 | $1,234 |
| Peerless Surgical Inc. | 1 | $820 |
| Atricure, Inc. | 5 | $217 |
| Johnson & Johnson | 5 | $217 |
| Stryker | 1 | $94 |
| Pacira Pharmaceuticals Incorporated | 3 | $86 |
| Avanos Medical | 1 | $72 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REAL INTELLIGENCE$104,006
- Journey II$77,150
- K-15 PORK$23,625
- POLARSTEM$13,740
- Legion Revision$12,081
- PICO$8,859
- JOURNEY$4,631
- R3 ACETABULAR$4,423
- EVOS$1,512
- POLARCUP$1,084
- REDAPT$1,084
- OR3O Dual Mobility$956
- RI.HIP NAVIGATION$956
- AETOS Shoulder System$946
- Legion$806
- Journey II BCS$174
- Velys$116
- SYNERGY ABLATION SYSTEM$113
How this compares
$140,468 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 170 | $9,025 |
| Celecoxib | 240 | $5,966 |
| Ondansetron OdtOndansetron | 123 | $1,209 |
| Oxycodone Hcl | 186 | $1,143 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 102 | $1,038 |
| Tramadol Hcl | 289 | $942 |
| Methocarbamol | 158 | $847 |
| Famotidine | 119 | $847 |
| Methylprednisolone | 98 | $699 |
| Meloxicam | 76 | $355 |
| Ondansetron Hcl | 115 | $324 |
| Amoxicillin | 81 | $175 |
| Diclofenac Sodium | 11 | $166 |
| Clindamycin Hcl | 13 | $45 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Newport Beach
- Hafiz KassamNewport Beach$1.1M
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Peter NewtonSan Diego$7M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.